Suppr超能文献

鉴定长链非编码 RNA ZEB1-AS1 介导的散发性肌萎缩侧索硬化症中的新通路。

Identification of a novel pathway in sporadic Amyotrophic Lateral Sclerosis mediated by the long non-coding RNA ZEB1-AS1.

机构信息

Pediatric Research Center "Romeo ed Enrica Invernizzi", Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.

Pediatric Research Center "Romeo ed Enrica Invernizzi", Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy; Department of Biology and Biotechnology "L. Spallanzani", University of Pavia, Pavia, Italy.

出版信息

Neurobiol Dis. 2023 Mar;178:106030. doi: 10.1016/j.nbd.2023.106030. Epub 2023 Feb 2.

Abstract

BACKGROUND

Deregulation of transcription in the pathogenesis of sporadic Amyotrophic Lateral Sclerosis (sALS) is taking central stage with RNA-sequencing analyses from sALS patients tissues highlighting numerous deregulated long non-coding RNAs (lncRNAs). The oncogenic lncRNA ZEB1-AS1 is strongly downregulated in peripheral blood mononuclear cells of sALS patients. In addition, in cancer-derived cell lines, ZEB1-AS1 belongs to a negative feedback loop regulation with hsa-miR-200c, acting as a molecular sponge for this miRNA. The role of the lncRNA ZEB1-AS1 in sALS pathogenesis has not been characterized yet, and its study could help identifying a possible disease-modifying target.

METHODS

the implication of the ZEB1-AS1/ZEB1/hsa-miR-200c/BMI1 pathway was investigated in multiple patients-derived cellular models (patients-derived peripheral blood mononuclear cells and induced pluripotent stem cells-derived neural stem cells) and in the neuroblastoma cell line SH-SY5Y, where its function was inhibited via RNA interference. Molecular techniques such as Real Time PCR, Western Blot and Immunofluorescence were used to assess the pathway dysregulation.

RESULTS

Our results show a dysregulation of a signaling pathway involving ZEB1-AS1/hsa-miR-200c/β-Catenin in peripheral blood mononuclear cells and in induced pluripotent stem cells-derived neural stem cells from sALS patients. These results were validated in vitro on the cell line SH-SY5Y with silenced expression of ZEB1-AS1. Moreover, we found an increase for ZEB1-AS1 during neural differentiation with an aberrant expression of β-Catenin, highlighting also its aggregation and possible impact on neurite length.

CONCLUSIONS

Our results support and describe the role of ZEB1-AS1 pathway in sALS and specifically in neuronal differentiation, suggesting that an impairment of β-Catenin signaling and an alteration of the neuronal phenotype are taking place.

摘要

背景

在散发性肌萎缩侧索硬化症(sALS)的发病机制中,转录失调占据了中心地位,sALS 患者组织的 RNA 测序分析强调了许多失调的长非编码 RNA(lncRNA)。致癌性 lncRNA ZEB1-AS1 在 sALS 患者的外周血单核细胞中强烈下调。此外,在癌症衍生的细胞系中,ZEB1-AS1 属于 hsa-miR-200c 的负反馈回路调节,作为该 miRNA 的分子海绵。lncRNA ZEB1-AS1 在 sALS 发病机制中的作用尚未得到表征,其研究有助于确定可能的疾病修饰靶点。

方法

在多个患者来源的细胞模型(患者来源的外周血单核细胞和诱导多能干细胞衍生的神经干细胞)和神经母细胞瘤细胞系 SH-SY5Y 中研究了 ZEB1-AS1/ZEB1/hsa-miR-200c/BMI1 通路的作用,并通过 RNA 干扰抑制其功能。采用实时 PCR、Western Blot 和免疫荧光等分子技术评估通路失调。

结果

我们的结果显示,ZEB1-AS1/hsa-miR-200c/β-Catenin 信号通路在 sALS 患者的外周血单核细胞和诱导多能干细胞衍生的神经干细胞中失调。这些结果在体外 SH-SY5Y 细胞系中得到了验证,该细胞系中 ZEB1-AS1 的表达被沉默。此外,我们发现 ZEB1-AS1 在神经分化过程中增加,β-Catenin 表达异常,这也突出了其聚集和对神经突长度的可能影响。

结论

我们的结果支持并描述了 ZEB1-AS1 通路在 sALS 中的作用,特别是在神经元分化中,表明 β-Catenin 信号受损和神经元表型改变。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验